21st March 2026, Saturday

TechPharus

Latest Posts

HealthTech News

  • Testosterone improves fat distribution for older women
    on March 21, 2026 at 5:30 pm

    As we age, the amount and distribution of fat in our bodies changes. Most fat is subcutaneous—meaning it is stored just under the skin. Subcutaneous fat generally does not have detrimental health impacts. In fact, we need some amount of fat to be healthy. Visceral fat, however, is stored in the gut and has been linked to negative health impacts, including diabetes and cardiovascular disease.

  • Discovery might inform new approach to Huntington’s disease
    on March 21, 2026 at 5:00 pm

    Treatments that target a fragment of the mutant protein that causes Huntington’s disease might be more effective than treatments—now in clinical trials—that target the whole protein but leave this fragment intact, a new study in mice suggests. The findings appear in Science Translational Medicine.

  • Novel blood marker may help predict cognitive impairment after a cardiac arrest
    on March 21, 2026 at 4:40 pm

    Routine early measurement of the neurofilament light chain could help improve prediction of cognitive impairment after out-of-hospital cardiac arrest, according to a study presented today at ESC Acute CardioVascular Care 2026, the annual congress of the Association for Acute CardioVascular Care (ACVC), a branch of the European Society of Cardiology (ESC).

  • TikTok: A vehicle for misinformation but also community-building for people with borderline personality disorder
    on March 21, 2026 at 4:30 pm

    Marie-Eve (not her real name) doesn’t know what to think anymore. After years of trying to make sense of her intense emotional crises, she went on TikTok and typed “#borderline” in the search bar. After watching a few videos, she recognized herself in the dozens of comments posted by other viewers.

  • A blood test may tailor breast cancer treatment for older women
    on March 21, 2026 at 4:00 pm

    For women age 70 and over with a common form of breast cancer, determining “the right size” of treatment can be challenging, in part because clinicians have limited tools to guide individualized treatment decisions. In a study published today in Clinical Cancer Research, scientists at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine found that a blood-based test may help guide treatment decisions for a carefully selected group of women age 70 and over who have estrogen receptor–positive breast cancer, who were considering endocrine (or hormone-blocking) therapy as the primary treatment and forgoing surgery and radiation.